Environment-responsive dopamine nanoplatform for tumor synergistic therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Photothermal therapy (PTT) shows promise for cancer treatment but faces limitations with deep-seated tumors due to near-infrared light penetration issues.
• Inefficient nanoparticle uptake by tumor cells can also reduce the effectiveness of PTT.

Purpose of the Study:

• To develop a synergistic treatment combining photothermal therapy and chemotherapy using novel nanoparticles.
• To enhance nanoparticle delivery and tumor cell uptake for improved therapeutic outcomes.

Main Methods:

• Polydopamine (PDA) nanoparticles were synthesized, loaded with doxorubicin (DOX) and indocyanine green (ICG).
• These nanoparticles were coated with folate acid-modified erythrocyte membranes (FA-EM) to create FA-EM@PDA/DOX&ICG.
• The efficacy of FA-EM@PDA/DOX&ICG nanoparticles was evaluated in vitro and in vivo.

Main Results:

• FA-EM@PDA/DOX&ICG nanoparticles demonstrated improved blood circulation time and targeted delivery to tumor tissues.
• Enhanced uptake by tumor cells via folate acid receptor binding was observed.
• Combined photothermal and chemotherapy effectively inhibited tumor growth with superior biocompatibility.

Conclusions:

• The developed FA-EM@PDA/DOX&ICG nanoparticles offer a promising strategy for synergistic cancer therapy.
• This approach overcomes limitations of traditional PTT and chemotherapy, showing significant therapeutic potential.